Article Details
Retrieved on: 2022-10-07 03:58:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a targeted therapy, immuno-oncology company ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here